FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julie Kish

Research Profile

Disorders

Chemicals & Drugs

Procedures

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John R Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K.S. Chao; Christopher J Schultz; Nancy Y Lee; Karen K Fu
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
David J Adelstein; Yi Li; George L Adams; Henry N Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
Julie A Kish; Jacqueline K Benedetti; Stanley P Balcerzak; R W Veith; R Davis; T W Pollock; D E Schuller; John F Ensley
Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julie Kish (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John R Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K.S. Chao; Christopher J Schultz; Nancy Y Lee; Karen K Fu
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
The New England journal of medicine 2004;350(19):1937-44.
2003: David J Adelstein; Yi Li; George L Adams; Henry N Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):92-8.
1999: Julie A Kish; Jacqueline K Benedetti; Stanley P Balcerzak; R W Veith; R Davis; T W Pollock; D E Schuller; John F Ensley
Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.
The cancer journal from Scientific American 1999;5(5):307-11.
1997: Julie A Kish; M K Wolf; P F Schellhammer; Maha Hussain; A B Einstein; E David Crawford
Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trial.
American journal of clinical oncology 1997;20(4):327-30.
1994: Julie A Kish; M Wolf; E D Crawford; J T Leimert; A Bueschen; J R Neefe; R C Flanigan
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group Study.
Cancer 1994;74(3):916-9.
1992: Arlene A Forastiere; B Metch; D E Schuller; John F Ensley; L F Hutchins; P Triozzi; Julie A Kish; S McClure; E VonFeldt; S K Williamson
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1245-51.
1991: R Cheruku; E Tapazoglou; John F Ensley; Julie A Kish; G D Cummings; M al-Sarraf
The incidence and significance of thromboembolic complications in patients with high-grade gliomas.
Cancer 1991;68(12):2621-4.
1991: M al-Sarraf; Julie A Kish; John F Ensley
The Wayne State University experience with adjuvant chemotherapy of head and neck cancer.
Hematology/oncology clinics of North America 1991;5(4):687-700.
1991: Maha Hussain; Julie A Kish; Lawrence R Crane; A Uwayda; G Cummings; John F Ensley; E Tapazoglou; M al-Sarraf
The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy.
Cancer 1991;67(3):716-21.
1991: Julie A Kish; K Kopecky; M K Samson; Daniel Von Hoff; W S Fletcher; R A Kempf; F M Muggia
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study.
Investigational new drugs 1991;9(1):105-8.
1990: Julie A Kish; John F Ensley; M al-Sarraf
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma.
American journal of clinical oncology 1990;13(1):17-8.
1989: F de Braud; Lance K Heilbrun; K Ahmed; Wael A Sakr; John F Ensley; Julie A Kish; E Tapazoglou; M al-Sarraf
Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment.
Cancer 1989;64(2):510-5.
1989: John F Ensley; Z Maciorowski; M Hassan; H Pietraszkiewicz; Lance K Heilbrun; Julie A Kish; E Tapazoglou; John R Jacobs; M al-Sarraf
Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck.
Cytometry 1989;10(3):334-8.
1989: John F Ensley; Julie A Kish; A A Weaver; John R Jacobs; M Hassan; G Cummings; M Al-Sarraf
The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy.
Cancer 1989;63(8):1487-92.
1989: John F Ensley; B Patel; Robert A Kloner; Julie A Kish; J Wynne; M al-Sarraf
The clinical syndrome of 5-fluorouracil cardiotoxicity.
Investigational new drugs 1989;7(1):101-9.
1988: Julie A Kish; John F Ensley; John R Jacobs; P Binns; M al-Sarraf
Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer.
American journal of clinical oncology 1988;11(5):553-7.
1988: E Tapazoglou; Julie A Kish; John F Ensley; M Al-Sarraf
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
American journal of clinical oncology 1988;11(4):474-8.
1988: K Al-Kourainy; JD Crissman; John F Ensley; Julie A Kish; J Kelly; M Al-Sarraf
Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.
American journal of clinical oncology 1988;11(4):427-30.
1988: John F Ensley; Julie A Kish; E Tapazoglou; John R Jacobs; A Weaver; D Atkinson; K Ahmed; Robert H Mathog; M Al-Sarraf
An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(7):1147-53.
1988: Patricia M LoRusso; E Tapazoglou; Julie A Kish; John F Ensley; G Cummings; J Kelly; M al-Sarraf
Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University.
Cancer 1988;62(1):1-5.
1987: John R Jacobs; A Weaver; K Ahmed; JD Crissman; John F Ensley; Julie A Kish; G Cummings; M al-Sarraf
Proto-chemotherapy in advanced head and neck cancer.
Head & neck surgery 1987;10(2):93-8.
1987: B Patel; Robert A Kloner; John F Ensley; M Al-Sarraf; Julie A Kish; J Wynne
5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.
The American journal of the medical sciences 1987;294(4):238-43.
1987: John F Ensley; Z Maciorowski; H Pietraszkiewicz; M Hassan; Julie A Kish; M Al-Sarraf; John R Jacobs; A Weaver; D Atkinson; JD Crissman
Solid tumor preparation for clinical application of flow cytometry.
Cytometry 1987;8(5):488-93.
1987: M Al-Sarraf; B Metch; Julie A Kish; John F Ensley; J J Rinehart; D E Schuller; C A Coltman
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.
Cancer treatment reports 1987;71(7-8):723-6.
1987: K Al-Kourainy; Julie A Kish; John F Ensley; E Tapazoglou; John R Jacobs; A Weaver; JD Crissman; G Cummings; M Al-Sarraf
Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer.
Cancer 1987;59(2):233-8.
1986: John R Jacobs; Julie A Kish; John F Ensley; K Ahmad; A Weaver; JD Crissman; M Al-Sarraf
Combined modality therapy utilizing a cisplatin combination for effective chemotherapy in patients with previously untreated head and neck cancer.
American journal of surgery 1986;152(4):451-5.
1986: Julie A Kish; John F Ensley; M Al-Sarraf
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Cancer treatment reports 1986;70(5):671-2.
1986: E Tapazoglou; Julie A Kish; John F Ensley; M Al-Sarraf
The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer.
Cancer 1986;57(6):1105-9.
1986: John F Ensley; JD Crissman; Julie A Kish; John R Jacobs; A Weaver; J Kinzie; G Cummings; M Al-Sarraf
The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy.
Cancer 1986;57(4):711-7.
1985: Julie A Kish; John F Ensley; John R Jacobs; A Weaver; G Cummings; M Al-Sarraf
A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
Cancer 1985;56(12):2740-4.
1985: M Rooney; Julie A Kish; John R Jacobs; J Kinzie; A Weaver; JD Crissman; M Al-Sarraf
Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.
Cancer 1985;55(5):1123-8.
1984: A Weaver; S Fleming; John F Ensley; Julie A Kish; John R Jacobs; J Kinzie; JD Crissman; M Al-Sarraf
Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer.
American journal of surgery 1984;148(4):525-9.
1984: John F Ensley; John R Jacobs; A Weaver; J Kinzie; JD Crissman; Julie A Kish; G Cummings; M Al-Sarraf
Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck.
Cancer 1984;54(5):811-4.
1984: Julie A Kish; A Weaver; John R Jacobs; G Cummings; M Al-Sarraf
Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck.
Cancer 1984;53(9):1819-24.
1982: A Weaver; S Flemming; Julie A Kish; H Vandenberg; J Jacob; JD Crissman; M Al-Sarraf
Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer.
American journal of surgery 1982;144(4):445-8.
1982: Julie A Kish; A Drelichman; John R Jacobs; J Hoschner; J Kinzie; J Loh; A Weaver; M Al-Sarraf
Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
Cancer treatment reports 1982;66(3):471-4.